» Authors » Joost Drenth

Joost Drenth

Explore the profile of Joost Drenth including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 694
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
de Vries E, Bolier R, Goet J, Pares A, Verbeek J, de Vree M, et al.
Gastroenterology . 2020 Oct; 160(3):734-743.e6. PMID: 33031833
Background And Aims: Pruritus may seriously impair quality of life in patients with cholestatic diseases such as primary or secondary sclerosing cholangitis (PSC, SSC) and primary biliary cholangitis (PBC). Pharmacologic...
2.
Veldhuijzen G, Klemt-Kropp M, Noomen C, Van Esch A, Tjwa E, Drenth J
Endosc Int Open . 2017 Aug; 5(8):E792-E797. PMID: 28791330
Background And Study Aims:  Better patient education prior to colonoscopy improves adherence to instructions for bowel preparation and leads to cleaner colons. We reasoned that computer assisted instruction (CAI) using...
3.
Lohr J, Dominguez-Munoz E, Rosendahl J, Besselink M, Mayerle J, Lerch M, et al.
United European Gastroenterol J . 2017 Mar; 5(2):153-199. PMID: 28344786
Background: There have been substantial improvements in the management of chronic pancreatitis, leading to the publication of several national guidelines during recent years. In collaboration with United European Gastroenterology, the...
4.
Wennmacker S, Lamberts M, Gerritsen J, Roukema J, Westert G, Drenth J, et al.
Surg Endosc . 2016 May; 31(1):215-224. PMID: 27194258
Background: Persistent postoperative pain (up to 41 %) and significant practice variation necessitate better patient selection for cholecystectomy. Patient-reported outcome measures (PROMs) are nowadays known to serve as a tool...
5.
Ratziu V, Harrison S, Francque S, Bedossa P, Lehert P, Serfaty L, et al.
Gastroenterology . 2016 Feb; 150(5):1147-1159.e5. PMID: 26874076
Background & Aims: Elafibranor is an agonist of the peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-δ. Elafibranor improves insulin sensitivity, glucose homeostasis, and lipid metabolism and reduces inflammation. We assessed...
6.
Drenth J, Wobbes T, Bonenkamp J, Nagengast F
Dig Dis Sci . 2002 Nov; 47(11):2598-604. PMID: 12452402
Fibrovascular esophageal polyps are rare benign tumors. They can grow to considerable length and cause symptoms such as dysphagia, retrosternal discomfort, vomiting, and even asphyxia. A barium contrast esophageal radiography...